Literature DB >> 16503896

Exclusive penile Kaposi's sarcoma: report of an HIV-negative man successfully treated with radiotherapy.

O Zargari1.   

Abstract

Kaposi's sarcoma (KS) is a rare neoplasm of endovascular cells with multifocal origin. The exact nature of the disease is not clear, but current data support the notion that KS is a vascular hyperplasia with a tight link to human herpesvirus 8 (HHV-8) infection. Classic KS occurs primarily on the lower extremities in elderly men living in the Mediterranean region. Penile involvement has rarely been reported in non-human immune deficiency virus (HIV) patients. Herein we present a 71-year-old HIV-negative man with isolated KS on the penis who was treated successfully with radiotherapy. A review of the literature is also presented.

Entities:  

Mesh:

Year:  2006        PMID: 16503896     DOI: 10.1111/j.1468-3083.2006.01423.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Primary Classic Kaposi's Sarcoma of the Penis in an HIV-Negative Patient.

Authors:  Kwang Ho Kim; Joon Il Choi; Kyoung Ho Ryu; In Ho Kang; Yi Hsueh Leng; Jun Woo Lee; Jong Woo Lee; Yoon Jung Kim; Jeong Ki Lee
Journal:  Korean J Urol       Date:  2010-11-17

2.  Disseminated Kaposi's Sarcoma with the Involvement of Penis in the Setting of HIV Infection.

Authors:  Maham Farshidpour; Majid Marjani; Parvaneh Baghaei; Payam Tabarsi; Heidar Masjedi; Zahra Farzaneh Asadi Kani; Seyed Alireza Nadji; Davood Mansouri
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

3.  Isolated Kaposi Sarcoma in two HIV negative patients.

Authors:  Iman Seleit; Abdalla Attia; Alaa Maraee; Rehab Samaka; Ola Bakry; Emad Eid
Journal:  J Dermatol Case Rep       Date:  2011-06-06

4.  Primary penile Kaposi's sarcoma in HIV-seronegative patient: a case report and literature review.

Authors:  Gianmartin Cito; Roberto Di Costanzo; Simone Morselli; Andrea Cocci; Raffaella Santi; Gabriella Nesi; Alessandro Natali; Andrea Minervini; Marco Carini; Fabrizio Travaglini
Journal:  Int Braz J Urol       Date:  2020 Sep-Oct       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.